Roivant Sciences Ltd (ROIV)

Current ratio

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	5,000,060	5,363,970	5,801,120	6,001,500	6,731,830	6,806,730	1,551,630	1,561,160	1,798,590	1,646,230	1,714,860	2,039,440	2,146,520	2,287,530	2,555,750	2,057,610	2,187,000	—
Total current liabilities	US$ in thousands	149,411	141,484	556,249	215,045	266,758	244,899	265,546	245,004	272,448	244,255	230,744	328,915	184,367	160,713	303,444	209,158	218,961	—
Current ratio		33.47	37.91	10.43	27.91	25.24	27.79	5.84	6.37	6.60	6.74	7.43	6.20	11.64	14.23	8.42	9.84	9.99	—

March 31, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $5,000,060K ÷ $149,411K
= 33.47

The current ratio of Roivant Sciences Ltd has shown significant fluctuations over the past few years. The current ratio measures the company's ability to cover its short-term liabilities with its short-term assets.

In December 2020, the current ratio was not available. From March 2021 to June 2022, the current ratio remained relatively stable, ranging between 9.99 and 6.20, indicating a strong ability to meet short-term obligations.

However, from September 2022 to March 2023, the current ratio experienced a decreasing trend, dropping to 5.84 in September 2023. This downward trend suggests potential difficulties in meeting short-term obligations with current assets.

The situation improved significantly in December 2023, with a substantial increase in the current ratio to 27.79. This surge indicates a significant strengthening of the company's ability to cover short-term liabilities with current assets.

Although there was a slight decrease in the current ratio in March 2024 and June 2024, it remained relatively strong at 25.24 and 27.91, respectively.

In September 2024, the current ratio dropped to 10.43, which may raise concerns about the company's short-term liquidity position. However, the ratio surged to 37.91 in December 2024, reflecting a significant improvement in the company's ability to meet short-term obligations.

The current ratio decreased to 33.47 in March 2025. Overall, the current ratio of Roivant Sciences Ltd has shown fluctuations, with periods of strong liquidity and also some volatility. This indicates the need for continuous monitoring of the company's liquidity position to ensure it can meet its short-term obligations effectively.